328 related articles for article (PubMed ID: 11945149)
1. COX selectivity and animal models for colon cancer.
Oshima M; Taketo MM
Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
[TBL] [Abstract][Full Text] [Related]
2. [COX inhibitor, suppression of polyposis, and chemoprevention].
Oshima M; Taketo MM
Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):276-84. PubMed ID: 12491803
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenases and colon cancer.
Kawai N; Tsujii M; Tsuji S
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():187-96. PubMed ID: 12432918
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
6. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
7. The role of cyclooxygenases in inflammation, cancer, and development.
Williams CS; Mann M; DuBois RN
Oncogene; 1999 Dec; 18(55):7908-16. PubMed ID: 10630643
[TBL] [Abstract][Full Text] [Related]
8. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
13. COX-2 and colon cancer.
Taketo MM
Inflamm Res; 1998 Oct; 47 Suppl 2():S112-6. PubMed ID: 9831333
[TBL] [Abstract][Full Text] [Related]
14. The role of COX-2 in intestinal cancer.
Williams C; Shattuck-Brandt RL; DuBois RN
Ann N Y Acad Sci; 1999; 889():72-83. PubMed ID: 10668484
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells.
Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
FEBS Lett; 2002 Nov; 531(2):278-84. PubMed ID: 12417326
[TBL] [Abstract][Full Text] [Related]
17. [COX-2 inhibitor and colon cancer].
Tsujii M
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
19. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality.
Rüegg C; Zaric J; Stupp R
Ann Med; 2003; 35(7):476-87. PubMed ID: 14649330
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
